Skip to content

Observation on the effect of homologous prescription of medicine and food in chronic fatigue syndrome

Observation on the effect of homologous prescription of medicine and food in chronic fatigue syndrome

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005527
Enrollment
Unknown
Registered
2022-01-11
Start date
2022-01-07
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic fatigue syndrome

Interventions

Sponsors

?????????
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Male or female participants aged 18-65 who were diagnosed with CFS according to CDC criteria; 2) Have not received any treatment for CFS in the past 1 month 3) Voluntarily provide signed consent forms. According to CDC standards, CFS patients must show the following symptoms: A) Persistent or recurrent fatigue for 6 months or more, not related to persistent fatigue or any other medical condition related to fatigue, B) fatigue and work that significantly interferes with personal activities C) Four or more concurrent symptoms (impaired short-term memory or concentration; Sore throat; Tenderness of cervical or axillary lymph nodes; Muscle pain; Multiple joint pain without joint swelling or redness; New headache, or severity; Unawake sleep; And discomfort lasting more than 24 hours after exercise).

Exclusion criteria

Exclusion criteria: 1) Male or female participants aged 18-65 who were diagnosed with CFS according to CDC criteria; 2) Have not received any treatment for CFS in the past 1 month 3) Voluntarily provide signed consent forms. According to CDC standards, CFS patients must show the following symptoms: A) Persistent or recurrent fatigue for 6 months or more, not related to persistent fatigue or any other medical condition related to fatigue, B) fatigue and work that significantly interferes with personal activities C) Four or more concurrent symptoms (impaired short-term memory or concentration; Sore throat; Tenderness of cervical or axillary lymph nodes; Muscle pain; Multiple joint pain without joint swelling or redness; New headache, or severity; Unawake sleep; And discomfort lasting more than 24 hours after exercise).

Design outcomes

Primary

MeasureTime frame
The questionnaire survey;

Countries

China

Contacts

Public ContactBin Luo
luobinyisheng@163.com18633889869

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026